Literature DB >> 21455379

Buprenorphine abuse in India : an update.

Y Sharma1, S K Mattoo.   

Abstract

This study reviews the available Indian literature on buprenorphine abuse. Buprenorphine was introduced in 1986; the abuse, first noticed in 1987, increased rapidly till 1994, and then decreased gradually. Initiated through other addicts and medical practitioners, the abuse was mostly as a cheap, easily and legally available substitute for opioids. The typical young adult male abuser used an intravenous cocktail with diazepam, pheneramine or promethazine for a better kick. The withdrawal syndrome was typical of the opioids and without an expected delayed onset. Complications of pseudoaneurysm and recurrent koro in repeated withdrawal were reported. Buprenorphine as a detoxifying agent for opioids reportedly gave better symptom control in the first week but high rates of dependence induction were reported. The Indian data tends to caution against the Western enthusiasm to use buprenorphine for detoxification or maintenance of opioid abusers.

Entities:  

Keywords:  Buprenorphine; India; substance abuse

Year:  1999        PMID: 21455379      PMCID: PMC2962840     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  17 in total

1.  Buprenorphine and temazepam--abuse.

Authors:  R Hammersley; T Lavelle; A Forsyth
Journal:  Br J Addict       Date:  1990-02

2.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Authors:  D R Jasinski; J S Pevnick; J D Griffith
Journal:  Arch Gen Psychiatry       Date:  1978-04

3.  Clinical pharmacology of buprenorphine: ceiling effects at high doses.

Authors:  S L Walsh; K L Preston; M L Stitzer; E J Cone; G E Bigelow
Journal:  Clin Pharmacol Ther       Date:  1994-05       Impact factor: 6.875

4.  Naloxone-induced withdrawal in patients with buprenorphine dependence.

Authors:  A K Nigam; R P Srivastava; S Saxena; B S Chavan; K R Sundaram
Journal:  Addiction       Date:  1994-03       Impact factor: 6.526

5.  HIV screening & risk behaviour in psychoactive substance users.

Authors:  A Malhotra; M Balaji; D Basu; S K Mattoo; V K Varma; S Sehgal
Journal:  Indian J Med Res       Date:  1993-11       Impact factor: 2.375

6.  Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.

Authors:  L Janiri; P Mannelli; A M Persico; A Serretti; E Tempesta
Journal:  Drug Alcohol Depend       Date:  1994-10       Impact factor: 4.492

7.  A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids.

Authors:  L J Cheskin; P J Fudala; R E Johnson
Journal:  Drug Alcohol Depend       Date:  1994-10       Impact factor: 4.492

8.  Buprenorphine suppresses heroin use by heroin addicts.

Authors:  N K Mello; J H Mendelson
Journal:  Science       Date:  1980-02-08       Impact factor: 47.728

9.  Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.

Authors:  L San; J Camí; T Fernández; J M Ollé; J M Peri; M Torrens
Journal:  Br J Addict       Date:  1992-01

10.  Pseudoaneurysm in injecting drug abusers: cases from India.

Authors:  D Basu; S K Mattoo; A Arora; A Malhotra; V K Varma
Journal:  Addiction       Date:  1994-12       Impact factor: 6.526

View more
  5 in total

1.  Promethazine use among chronic pain patients.

Authors:  Kara L Lynch; Brad J Shapiro; Diana Coffa; Scott P Novak; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2015-02-26       Impact factor: 4.492

2.  Controlled trial of maintenance treatment of intravenous buprenorphine dependence.

Authors:  J Ahmadi; K Ahmadi
Journal:  Ir J Med Sci       Date:  2003 Oct-Dec       Impact factor: 1.568

3.  Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence.

Authors:  Disa Dahlman; Tove Abrahamsson; Alex H Kral; Anders Hakansson
Journal:  J Addict       Date:  2016-12-20

Review 4.  Research on opioid substitution therapy in India: A brief, narrative review.

Authors:  Atul Ambekar; Ravindra Rao; Alok Agrawal; Preethy Kathiresan
Journal:  Indian J Psychiatry       Date:  2018 Jul-Sep       Impact factor: 1.759

5.  A novel approach in the detoxification of intravenous buprenorphine dependence.

Authors:  Sukanto Sarkar; Eswaran Subramaniam; Janet Konthoujam
Journal:  Indian J Psychiatry       Date:  2016 Apr-Jun       Impact factor: 1.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.